Stocks and Investing
Stocks and Investing
Fri, May 11, 2018
[ 12:00 AM ] - United States, WOPRAI
Thu, May 10, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, May 9, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Elemer Piros Upgraded (ARWR) to Buy on, May 9th, 2018
Elemer Piros of Cantor Fitzgerald, Upgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Buy on, May 9th, 2018.
Elemer has made no other calls on ARWR in the last 4 months.
There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 1 agrees with Elemer's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Madhu Kumar of "B. Riley Securities" Maintained at Hold with Increased Target to $4 on, Monday, February 12th, 2018
This is the rating of the analyst that currently disagrees with Elemer
- Maury Raycroft of "Jefferies" Initiated at Strong Buy and Held Target at $10 on, Tuesday, March 27th, 2018
Contributing Sources